Market Cap 749.86M
Revenue (ttm) 65.56M
Net Income (ttm) 17.19M
EPS (ttm) N/A
PE Ratio 39.40
Forward PE 36.18
Profit Margin 26.22%
Debt to Equity Ratio 0.00
Volume 50,100
Avg Vol 43,538
Day's Range N/A - N/A
Shares Out 12.67M
Stochastic %K 96%
Beta 0.81
Analysts Strong Sell
Price Target $60.00

Latest News on IRMD

IRADIMED CORPORATION (IRMD) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:52 PM EDT - 2 months ago

IRADIMED CORPORATION (IRMD) Q3 2024 Earnings Call Transcript


IRADIMED CORPORATION (IRMD) Q2 2024 Earnings Call Transcript

Aug 3, 2024, 6:17 PM EDT - 6 months ago

IRADIMED CORPORATION (IRMD) Q2 2024 Earnings Call Transcript


IRADIMED CORPORATION (IRMD) Q1 2024 Earnings Call Transcript

May 4, 2024, 1:27 PM EDT - 9 months ago

IRADIMED CORPORATION (IRMD) Q1 2024 Earnings Call Transcript


IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 6:20 PM EST - 1 year ago

IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript


IRadimed Corporation (IRMD) Q3 2023 Earnings Call Transcript

Nov 3, 2023, 1:30 PM EDT - 1 year ago

IRadimed Corporation (IRMD) Q3 2023 Earnings Call Transcript


IRadimed: Incremental Profit Gains, Reiterate Buy

Jun 9, 2023, 1:28 PM EDT - 1 year ago

IRadimed: Incremental Profit Gains, Reiterate Buy


IRadimed Corporation (IRMD) Q1 2023 Earnings Call Transcript

May 8, 2023, 2:25 AM EDT - 1 year ago

IRadimed Corporation (IRMD) Q1 2023 Earnings Call Transcript


IRADIMED CORPORATION Issues Urgent Medical Device Correction

Feb 24, 2023, 4:15 PM EST - 2 years ago

IRADIMED CORPORATION Issues Urgent Medical Device Correction


IRadimed: Revise To Buy With Exceptional Incremental ROIC In Q4

Feb 10, 2023, 10:45 AM EST - 2 years ago

IRadimed: Revise To Buy With Exceptional Incremental ROIC In Q4


IRadimed Corporation (IRMD) Q4 2022 Earnings Call Transcript

Feb 2, 2023, 2:05 PM EST - 2 years ago

IRadimed Corporation (IRMD) Q4 2022 Earnings Call Transcript